Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PEERLESS Study

NCT05111613 is registered in ClinicalTrials.gov with Inari Medical as lead sponsor.

NCT NCT05111613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05111613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PEERLESS Study
Lead sponsor
Inari Medical
Phase
Not applicable
Overall status
Completed
Start date
February 14, 2022
Completion date
April 11, 2024
Enrollment
692 (actual)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism, pulmonary thromboembolism